McKinsey Drove Opioid Sale Scheme, Endo Ch. 11 Trust Says
By Clara Geoghegan · August 16, 2024, 7:51 PM EDT
Consulting giant McKinsey & Co. should pay at least $1.5 billion to cover costs pharmaceutical developer Endo International racked up defending against claims that it helped drive the opioid crisis, an...
To view the full article, register now.